IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases

Autoimmun Rev. 2018 Dec;17(12):1176-1185. doi: 10.1016/j.autrev.2018.06.008. Epub 2018 Oct 12.

Abstract

The pro-inflammatory cytokine interleukin(IL)-17 and IL-17-producing cells are important players in the pathogenesis of many autoimmune / inflammatory diseases. More recently, they have been associated with liver diseases. This review first describes the general knowledge on IL-17 and IL-17 producing cells. The second part describes the in vitro and in vivo effects of IL-17 on liver cells and the contribution of IL-17 producing cells to liver diseases. IL-17 induces immune cell infiltration and liver damage driving to hepatic inflammation and fibrosis and contributes to autoimmune liver diseases. The circulating levels of IL-17 and the frequency of IL-17-producing cells are elevated in a variety of acute and chronic liver diseases. The last part focuses on the effects of IL-17 deletion or neutralization in various murine models. Some of these observed beneficial effects suggest that targeting the IL-17 axis could be a new therapeutic strategy to prevent chronicity and progression of various liver diseases.

Keywords: Th17 cell; autoimmune liver disease; hepatitis; interleukin-17.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / immunology*
  • Autoimmune Diseases / metabolism
  • Autoimmune Diseases / pathology*
  • Humans
  • Interleukin-17 / immunology
  • Interleukin-17 / metabolism*
  • Liver Diseases / immunology*
  • Liver Diseases / metabolism
  • Liver Diseases / pathology*

Substances

  • Interleukin-17